PennyStock101

ALPN - One Target Hit. Going Again.

Long
NASDAQ:ALPN   Alpine Immune Sciences, Inc
Alpine Immune Sciences , Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

SHORT INTEREST
22. 54K 08/15/19

P/E Current
-1.86

P/E Ratio (with extraordinary items)
-1.92

Average Recommendation: BUY

Average Target Price: 13.50

Your Intro To Penny Stock Trading Success...

1) Sign Up for our 100% Free Email Newsletter:
http://www.PennyStock101.org

2) Follow our Telegram Channel @ https://t.me/PennyStock101

3) Join our LIVE CHAT on Discord @ https://discord.gg/qSVhafy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.